Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection

Clinical and molecular hepatology

Volumn 22, Issue 2, 2016, Pages 259-266

  Nam, Hee Chul ^a   Lee, Hae Lim ^a   Yang, Hyun ^a   Song, Myeong Jun ^a  

^a Daejeon St Mary's Hospital   (South Korea)

Author keywords

Asunaprevir; Daclatasvir; Direct acting antivirals; Hepatitis C virus; Liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; ASUNAPREVIR; BMS-790052; IMIDAZOLE DERIVATIVE; ISOQUINOLINE DERIVATIVE; SULFONAMIDE; VIRUS RNA;

AGED; ANTIVIRAL RESISTANCE; BLOOD; COMBINATION DRUG THERAPY; COMPLICATION; DIAGNOSTIC IMAGING; DRUG ADMINISTRATION; FEMALE; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMAN; ISOLATION AND PURIFICATION; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY;

AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMIDAZOLES; ISOQUINOLINES; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; SULFONAMIDES; TREATMENT OUTCOME;

EID: 85050580060     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2016.0020     Document Type: Article

References (0)